Efficacy News and Research

RSS
Reduced-intensity benefits confirmed for AML cell transplantation

Reduced-intensity benefits confirmed for AML cell transplantation

Navidea commences enrollment in [18F]NAV4694 Phase 2 study for Alzheimer's

Navidea commences enrollment in [18F]NAV4694 Phase 2 study for Alzheimer's

Xenex's pulsed xenon UV more effective than bleach in decontaminating C. diff surfaces

Xenex's pulsed xenon UV more effective than bleach in decontaminating C. diff surfaces

Pfizer announces that 14 abstracts for tofacitinib to be presented at ACR/ARHP annual meeting

Pfizer announces that 14 abstracts for tofacitinib to be presented at ACR/ARHP annual meeting

Compelling data from two ITS Flunisyn Phase I clinical trials against multiple strains of influenza A

Compelling data from two ITS Flunisyn Phase I clinical trials against multiple strains of influenza A

Sentara Heart Hospital performs first innovative Atrial Fibrillation procedure

Sentara Heart Hospital performs first innovative Atrial Fibrillation procedure

Pertussis immunity wanes in the 5 years after DTaP vaccination

Pertussis immunity wanes in the 5 years after DTaP vaccination

Antimuscarinics only moderately effective for overactive bladder

Antimuscarinics only moderately effective for overactive bladder

Nanoparticles for non-invasive photodynamic therapy of deep cancer

Nanoparticles for non-invasive photodynamic therapy of deep cancer

Anthera to initiate blisibimod Phase 3 program for systemic lupus erythematosus

Anthera to initiate blisibimod Phase 3 program for systemic lupus erythematosus

FDA designates Rib-X's delafloxacin as QIDP for acute bacterial skin and skin structure infections

FDA designates Rib-X's delafloxacin as QIDP for acute bacterial skin and skin structure infections

VTT, GE Healthcare enter collaboration for AD research

VTT, GE Healthcare enter collaboration for AD research

Biocompatibles, Philips to develop new treatment protocol for trans-arterial embolization

Biocompatibles, Philips to develop new treatment protocol for trans-arterial embolization

Viewpoints: Medicaid's role in lowering uninsured rate; Need to protect physicians 'compelled by conscience' to provide abortions

Viewpoints: Medicaid's role in lowering uninsured rate; Need to protect physicians 'compelled by conscience' to provide abortions

FDA clears Tangent Medical’s NovaCath Secure IV Catheter System

FDA clears Tangent Medical’s NovaCath Secure IV Catheter System

Sun-protection counseling by medical staff ineffective

Sun-protection counseling by medical staff ineffective

Gefitinib shows promise in Chinese lung cancer patients

Gefitinib shows promise in Chinese lung cancer patients

Crizotinib may be effective treatment option for NSCLC subtype

Crizotinib may be effective treatment option for NSCLC subtype

Nature examines efforts to combat antibiotic resistance in India

Nature examines efforts to combat antibiotic resistance in India

Biodel initiates BIOD-123 Phase 2 trial in Type 1 diabetes

Biodel initiates BIOD-123 Phase 2 trial in Type 1 diabetes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.